Peptide-directed delivery of drug-loaded nanocarriers targeting CD36 overexpressing cells

[1]  J. Meng,et al.  Peptide-enabled receptor-binding-quantum dots for enhanced detection and migration inhibition of cancer cells , 2020, Journal of Biomaterials Science. Polymer Edition.

[2]  P. Weiss,et al.  Principles of Inter-Amino-Acid Recognition Revealed by Binding Energies between Homogeneous Oligopeptides , 2019, ACS central science.

[3]  Kinam Park.  Multi-functional peptide-modified liposomes for treatment of glioma. , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[4]  B. Qiu,et al.  Peptide-modified vemurafenib-loaded liposomes for targeted inhibition of melanoma via the skin. , 2018, Biomaterials.

[5]  Camille Stephan-Otto Attolini,et al.  Targeting metastasis-initiating cells through the fatty acid receptor CD36 , 2016, Nature.

[6]  J. Meng,et al.  Improving chemotherapeutic efficiency in acute myeloid leukemia treatments by chemically synthesized peptide interfering with CXCR4/CXCL12 axis , 2015, Scientific Reports.

[7]  L. Roberts,et al.  Elevated free fatty acid uptake via CD36 promotes epithelial-mesenchymal transition in hepatocellular carcinoma , 2015, Scientific Reports.

[8]  M. B. Xia,et al.  Recent advances in fatty acid perception and genetics. , 2015, Advances in nutrition.

[9]  J. Meng,et al.  A designed peptide targeting CXCR4 displays anti-acute myelocytic leukemia activity in vitro and in vivo , 2014, Scientific Reports.

[10]  Zhiyuan Hu,et al.  Label-Free Quantitative Detection of Tumor-Derived Exosomes through Surface Plasmon Resonance Imaging , 2014, Analytical chemistry.

[11]  Chen Wang,et al.  Peptide-based isolation of circulating tumor cells by magnetic nanoparticles. , 2014, Journal of materials chemistry. B.

[12]  Zhonghua Wu,et al.  Cationic amphiphilic drugs self-assemble to the core–shell interface of PEGylated phospholipid micelles and stabilize micellar structure , 2013, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences.

[13]  S. Misra,et al.  Molecular Basis of Antiangiogenic Thrombospondin-1 Type 1 Repeat Domain Interactions With CD36 , 2013, Arteriosclerosis, Thrombosis and Vascular Biology.

[14]  Xing-jie Liang,et al.  Functionalized nanoscale micelles improve drug delivery for cancer therapy in vitro and in vivo. , 2013, Nano letters.

[15]  Jing Wang,et al.  Delivery of drugs to cell membranes by encapsulation in PEG-PE micelles. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[16]  Y. Barenholz.  Doxil®--the first FDA-approved nano-drug: lessons learned. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[17]  Jing Wang,et al.  Pegylated phospholipid micelles induce endoplasmic reticulum-dependent apoptosis of cancer cells but not normal cells. , 2012, ACS nano.

[18]  L. Qin,et al.  Stability Influences the Biodistribution, Toxicity, and Anti-tumor Activity of Doxorubicin Encapsulated in PEG-PE Micelles in Mice , 2012, Pharmaceutical Research.

[19]  Xin-guo Jiang,et al.  Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery. , 2011, Biomaterials.

[20]  Anna Waller,et al.  Simultaneous in vitro molecular screening of protein-peptide interactions by flow cytometry, using six Bcl-2 family proteins as examples , 2011, Nature Protocols.

[21]  R. Manavalan,et al.  Nanotherapeutics to overcome conventional cancer chemotherapy limitations. , 2011, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[22]  Ruth Nussinov,et al.  Nanoparticle-induced vascular blockade in human prostate cancer. , 2010, Blood.

[23]  Xiuli Wei,et al.  Nanoparticle delivery strategies to target doxorubicin to tumor cells and reduce side effects. , 2010, Therapeutic delivery.

[24]  Erkki Ruoslahti,et al.  Targeting of drugs and nanoparticles to tumors , 2010, The Journal of cell biology.

[25]  Cristina Carvalho,et al.  Doxorubicin: the good, the bad and the ugly effect. , 2009, Current medicinal chemistry.

[26]  Zhiyuan Hu,et al.  SPR imaging for high throughput, label-free interaction analysis. , 2009, Combinatorial chemistry & high throughput screening.

[27]  E. Ruoslahti,et al.  Effect of the lipid chain melting transition on the stability of DSPE-PEG(2000) micelles. , 2009, Langmuir : the ACS journal of surfaces and colloids.

[28]  Wei Liang,et al.  Improving penetration in tumors with nanoassemblies of phospholipids and doxorubicin. , 2007, Journal of the National Cancer Institute.

[29]  Sushma Talegaonkar,et al.  Development and bioavailability assessment of ramipril nanoemulsion formulation. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[30]  P. Hardy,et al.  Activation of CD36 inhibits and induces regression of inflammatory corneal neovascularization. , 2006, Investigative ophthalmology & visual science.

[31]  G. Eytan.  Mechanism of multidrug resistance in relation to passive membrane permeation. , 2005, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[32]  H. Ueno,et al.  Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin , 2004, British Journal of Cancer.

[33]  Kristian Pietras,et al.  High interstitial fluid pressure — an obstacle in cancer therapy , 2004, Nature Reviews Cancer.

[34]  R. Silverstein,et al.  CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. , 2001, The Journal of clinical investigation.

[35]  G. Crabtree,et al.  Affinity modulation of small-molecule ligands by borrowing endogenous protein surfaces. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[36]  S. Ryeom,et al.  Binding of Anionic Phospholipids to Retinal Pigment Epithelium May Be Mediated by the Scavenger Receptor CD36* , 1996, The Journal of Biological Chemistry.

[37]  J. Saczko,et al.  Nanoemulsion-templated polylelectrolyte multifunctional nanocapsules for DNA entrapment and bioimaging. , 2016, Colloids and surfaces. B, Biointerfaces.

[38]  F. Shakeel,et al.  Transdermal delivery of anticancer drug caffeine from water-in-oil nanoemulsions. , 2010, Colloids and surfaces. B, Biointerfaces.

[39]  R K Jain,et al.  Transport of molecules, particles, and cells in solid tumors. , 1999, Annual review of biomedical engineering.